Xin H. Liu

Anhui Province Key Laboratory Of Major Autoimmune Diseases
Hefei, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Description of a new species of the genus Riukiaria (Diplopoda, Polydesmida, Xystodesmidae) from eastern China, with the characterization of its complete mitochondrial genome.

Description of a new species of the genus Riukiaria (Diplopoda, Polydesmida, Xystodesmidae) from eastern China, with the characterization of its complete mitochondrial genome.

Journal: ZooKeys

Published: December 19, 2025

Discovery of novel and potent CDK8 inhibitors for the treatment of acute myeloid leukaemia.

Discovery of novel and potent CDK8 inhibitors for the treatment of acute myeloid leukaemia.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: January 23, 2024

The discovery of a novel pyrrolo[2,3-b]pyridine as a selective CDK8 inhibitor offers a new approach against psoriasis.

The discovery of a novel pyrrolo[2,3-b]pyridine as a selective CDK8 inhibitor offers a new approach against psoriasis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 19, 2023

Discovery of a novel oral type Ⅰ CDK8 inhibitor against acute myeloid leukemia.

Discovery of a novel oral type Ⅰ CDK8 inhibitor against acute myeloid leukemia.

Journal: European journal of medicinal chemistry

Published: December 16, 2022

Design and Synthesis of a 2-Amino-pyridine Derivative as a Potent CDK8 Inhibitor for Anti-colorectal Cancer Therapy.

Design and Synthesis of a 2-Amino-pyridine Derivative as a Potent CDK8 Inhibitor for Anti-colorectal Cancer Therapy.

Journal: Journal of medicinal chemistry

Published: September 20, 2022

Discovery of the Novel 1H-Pyrrolo[2,3-b]pyridine Derivative as a Potent Type II CDK8 Inhibitor against Colorectal Cancer.

Discovery of the Novel 1H-Pyrrolo[2,3-b]pyridine Derivative as a Potent Type II CDK8 Inhibitor against Colorectal Cancer.

Journal: Journal of medicinal chemistry

Published: September 07, 2022

Discovery of novel paeonol-based derivatives against skin inflammation in vitro and in vivo.

Discovery of novel paeonol-based derivatives against skin inflammation in vitro and in vivo.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: February 28, 2022

Discovery of Novel Pterostilbene-Based Derivatives as Potent and Orally Active NLRP3 Inflammasome Inhibitors with Inflammatory Activity for Colitis.

Discovery of Novel Pterostilbene-Based Derivatives as Potent and Orally Active NLRP3 Inflammasome Inhibitors with Inflammatory Activity for Colitis.

Journal: Journal of medicinal chemistry

Published: September 10, 2021

Cathepsin C inhibitors as anti-inflammatory drug discovery: Challenges and opportunities.

Cathepsin C inhibitors as anti-inflammatory drug discovery: Challenges and opportunities.

Journal: European journal of medicinal chemistry

Published: August 04, 2021

1,3,4-thiadiazole: a privileged scaffold for drug design and development.

1,3,4-thiadiazole: a privileged scaffold for drug design and development.

Journal: Current topics in medicinal chemistry

Published: June 20, 2021

Transition Metal-mediated Uncaging Chemistry in Prodrug Design.

Transition Metal-mediated Uncaging Chemistry in Prodrug Design.

Journal: Current topics in medicinal chemistry

Published: February 03, 2021

Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety.

Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: December 28, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026